Back
Alnylam Pharmaceuticals Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
27
ALNY
Alnylam Pharmaceuticals
Last Price:
$230.50
Seasonality Move:
13.24%
Sell
25
CRSP
CRISPR Therapeutics AG
Last Price:
$37.79
Seasonality Move:
26.86%
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $230.50. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $37.78. The Score for CRSP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $230.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $37.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.87 | Sell |
Relative Strength Index (14 RSI): | 42.27 | Sell |
Chaikin Money Flow: | 76508 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (233.82 - 270.84) | Sell |
Bollinger Bands (100): | (237.3 - 267) | Sell |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.65 | Buy |
Relative Strength Index (14 RSI): | 49.49 | Sell |
Chaikin Money Flow: | 299518 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.05 - 41.49) | Buy |
Bollinger Bands (100): | (37.68 - 47.48) | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 233.25 | Sell |
20-day SMA: | 253.69 | Sell |
50-day SMA: | 253.99 | Sell |
200-day SMA: | 258.78 | Sell |
8-day EMA: | 236.65 | Sell |
20-day EMA: | 245.1 | Sell |
50-day EMA: | 251.11 | Sell |
200-day EMA: | 244.31 | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.96 | Buy |
20-day SMA: | 36.72 | Buy |
50-day SMA: | 40.94 | Sell |
200-day SMA: | 46.3 | Sell |
8-day EMA: | 36.64 | Buy |
20-day EMA: | 31.44 | Buy |
50-day EMA: | 20.09 | Buy |
200-day EMA: | 6.64 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.95 per share, an increase next quarter of $1.35 per share, an increase this year of $1.05 per share, and an increase next year of $2.86 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.02 per share, an increase this year of $0.24 per share, and an increase next year of $0.91 per share.
Alnylam Pharmaceuticals Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |